Ibalgin Baby

Ibuprofen, the active ingredient in Ibalgin Baby, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral suspension for pediatric use. It provides analgesic, antipyretic and anti‑inflammatory effects for infants and young children experiencing pain or fever.

GNH USA supplies Ibalgin Baby as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with European Union regulatory requirements and is manufactured under GMP conditions. It is distributed to a broad network of healthcare providers across multiple continents, ensuring timely access to pediatric fever and pain management.

Ibuprofen, the active ingredient in Ibalgin Baby, is used to manage conditions involving inflammation, pain, or fever in the pediatric population. - Fever: Reduces elevated body temperature in infants and young children. - Mild to moderate pain: Alleviates pain from teething, ear infections, sore throat, or minor injuries. - Inflammatory conditions: Provides symptomatic relief in juvenile inflammatory disorders such as juvenile idiopathic arthritis. - Post‑vaccination discomfort: Decreases soreness and low‑grade fever following routine immunizations.

Ibalgin Baby, like other ibuprofen preparations, may be associated with a range of adverse reactions.

Common Side Effects: - Nausea or vomiting: mild gastrointestinal upset that may occur after dosing. - Diarrhea or abdominal discomfort: transient stomach irritation. - Rash or mild skin itching: occasional allergic skin reaction. - Headache or dizziness: transient central nervous system effects.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration: severe stomach or intestinal bleeding. - Severe allergic reaction: anaphylaxis, angioedema, or Stevens‑Johnson syndrome. - Renal impairment: reduced kidney function, especially with dehydration. - Hepatic dysfunction: elevated liver enzymes or hepatitis.

When using Ibalgin Baby, several precautions should be observed to minimize risk. - Age restriction: Not recommended for infants under 3 months without medical advice. - Dose accuracy: Use a calibrated measuring device to ensure correct volume. - Dehydration risk: Avoid use in children who are severely dehydrated or ill with fever. - Concomitant NSAIDs: Do not combine with other NSAIDs or aspirin to reduce gastrointestinal toxicity. - Underlying conditions: Caution in children with asthma, kidney disease, or liver impairment. - Store at ambient temperature: Keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Ibuprofen can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - High‑dose corticosteroids: heightened gastrointestinal ulcer risk. - Selective serotonin reuptake inhibitors (SSRIs): potential for bleeding complications.

Moderate Interactions (Monitor Closely): - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Lithium: ibuprofen may raise lithium serum levels. - Methotrexate: reduced clearance leading to toxicity.